Filler Risks Revealed: The Genetic Test That Personalizes Your Aesthetic Treatments
Cosmetic fillers are a popular and effective way to enhance facial features and reduce the appearance of wrinkles and lines. However, like any medical procedure, there are potential risks involved. In some cases, patients may develop adverse reactions to the fillers, such as swelling, redness, and pain.
These reactions are typically short-lived and can be treated with medication, but in rare cases, they can lead to more serious complications. The risk of adverse reactions to fillers is not uniform across all patients and is influenced by a range of factors, including the type of filler used, the location of the injection, and the individual's immune system. Recently, a genetic test has been developed that can predict an individual's risk of developing adverse reactions to fillers based on their DNA. In this article, we will explore the potential risks of cosmetic fillers and how the genetic test can help to personalize aesthetic treatments and minimize the risk of adverse reactions.
Filler Safety Made Simple with Fagron FillerTest
Fagron FillerTest is an innovative immunogenetic test designed to help individuals who are considering getting fillers. The test aims to inform patients if they have a genetic predisposition that causes their immune system to react excessively to fillers. This overreaction can cause adverse effects such as swelling, redness, and pain. By taking the FillerTest, patients can make an informed decision about whether fillers are a safe option for them.
The FillerTest works by analyzing an individual's DNA to determine if they carry specific genetic markers that are associated with an increased risk of immune system reactions to fillers. The test is non-invasive and can be performed in a medical office or clinic. This test is an excellent option for individuals who have had adverse reactions to fillers in the past or those who want to avoid potential risks associated with filler treatments. By identifying potential risks, patients can make a more informed decision about whether fillers are a safe option for them.
Q & A - About Fagron Filler Test
Q: How accurate is the Filler result apart from just the -ve risk and +ve risk/complications result?
A: The accuracy of the Filler result is based on the lab that performs the DNA analysis of the patient's samples. Specifically, the Fagron genomics lab, which guarantees a 99% accuracy in identifying the two HLAs involved in the analysis. In terms of accuracy regarding the risk of complications, scientific research has shown that patients who test positive for a specific combination of HLA haplotypes have a high risk of developing late-onset, inflammatory immune-mediated reactions to fillers over time (more than 90% risk; OR>4).
Q: There are different fillers with separate ingredients; is the result specifying each risk or just the -ve and +ve risk results in general?
A: The Filler test predicts adverse reactions to any biomaterial, including different types of fillers, as confirmed by scientific validation studies that included different cohorts of controls and patients with various fillers, including patients with only one filler per patient or multiple fillers per patient. The genetic test provides general data on the individual's immunological background against foreign body materials, including recent scientific evidence that genetic predisposition can cause adverse immune reactions to breast implants. However, a test result does not specify the risk for each individual filler or ingredient.
Q: Can the clinic deny patients just by saying they have a positive risk result, and will this create a trust issue with the clinic and patients?
A: The Filler test aims to personalize treatment for patients based on their genetic predisposition. In the case of a positive test result, the clinic will not deny treatment but instead personalize the treatment to ensure the patient receives the right treatment. Specifically, a positive test result means that the patient has a high risk of developing late-onset immune reactions to normal filler treatments, and it is not recommended to proceed with the filler treatment. Alternative treatments, such as BOTOX, Lipofilling, stem cells, PRP, Facial Laser, or RF treatments, can be considered. If a patient decides to go to another clinic and receive filler treatment, there is a high chance (>90%) of developing late-onset immune reactions, but these reactions are not immediate and may occur from 3 to 6 months or even years later.